Cytokinetics CYTK Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's net change in cash?
- Cytokinetics (CYTK) reported net change in cash of $7.32M in Q1 2026.
- How has Cytokinetics's net change in cash changed year-over-year?
- Cytokinetics's net change in cash increased by 134.6% year-over-year, from -$21.18M to $7.32M.
- What does net change in cash mean?
- The total change in the company's cash balance over the period.
- How do you interpret net change in cash?
- A positive change indicates a net increase in liquidity, while a negative change indicates a net consumption of cash reserves.
- How does net change in cash compare across companies?
- A fundamental liquidity metric reported by all companies; critical for assessing cash burn in pre-revenue biotech firms.